Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 17, Issue 9, Pages 835-843Publisher
TAYLOR & FRANCIS AS
DOI: 10.1080/14737159.2017.1364160
Keywords
Inflammatory bowel disease; fecal markers; serology; diagnosis; prognosis; outcomes
Categories
Ask authors/readers for more resources
Introduction: Diagnosis of the chronic inflammatory bowel diseases relies upon initial recognition of an inflammatory condition, followed by definitive endoscopic, histological and radiological investigations. Various biomarkers are available to assist with initial elucidation of an inflammatory process: these also have important roles after diagnosis in monitoring and ongoing assessment of progress. Areas covered: Various inflammatory markers, serological tests and genetic analyses may be helpful in predicting the course of disease in the coming months. This review provides an update on the current understanding and knowledge about these markers. It also highlights key gaps and identifies aspects that require further study. Expert commentary: Our current approach to the application of non-invasive biomarkers is rudimentary. Further work is required to elucidate the roles of the various markers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available